Schafer Joshua
CCO
Schafer Joshua has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 4, 2026.
On the most recent filing, Schafer Joshua is listed as CCO at ZEVRA THERAPEUTICS, INC. Inside the rolling window, Schafer Joshua reported no open-market purchases and 2 open-market sales totaling $126K in ZVRA. The largest disclosed transaction in the window is a sale of 10,500 ZVRA shares on Feb 3, 2026, worth $97K.
Companies traded
Other insiders at ZVRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$126K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schafer Joshua made?
Schafer Joshua has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Schafer Joshua trade?
Schafer Joshua has filed SEC Form 4 disclosures for 1 company, including ZVRA.
When was Schafer Joshua's most recent SEC Form 4 filing?
Schafer Joshua's most recent SEC Form 4 filing on Tracefour is dated Feb 4, 2026.
What is Schafer Joshua's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Schafer Joshua is listed as CCO.
What is Schafer Joshua's total buy and sell value in the current window?
Inside the rolling retention window, Schafer Joshua bought $0 and sold $126K based on SEC Form 4 filings.
What was Schafer Joshua's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,500 ZVRA shares on 2026-02-03, worth $97K, per SEC Form 4 filings.